Marshall Wace’s Coherus Oncology CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$727K Buy
2024
Q1
$362K Buy
2023
Q4
$390K Sell
2023
Q3
$8.65M Buy
2023
Q2
$9.75M Buy
2023
Q1
$3.92M Buy
2022
Q4
Sell
2022
Q3
$294K Buy
2021
Q2
Sell
2021
Q1
$505K Buy
2019
Q3
Sell
2019
Q2
$207K Buy
2018
Q4
Sell
2018
Q3
$3.91M Buy
2018
Q2
$369K Buy
2017
Q1
Sell
2016
Q4
$1.02M Buy